Health Care & Life Sciences » Biotechnology | Oxford Immunotec Global PLC

Oxford Immunotec Global PLC | Ownership

Companies that own Oxford Immunotec Global PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Invesco Asset Management Ltd.
2,966,230
11.42%
-117,218
0.06%
06/30/2018
Polar Capital LLP
2,500,022
9.63%
0
0.08%
06/30/2018
Consonance Capital Management LP
2,339,184
9.01%
0
1.84%
06/30/2018
Redmile Group LLC
2,235,207
8.61%
-234,480
1.02%
06/30/2018
Alyeska Investment Group LP
1,614,215
6.22%
52,159
0.23%
06/30/2018
Deerfield Management Company LP
1,311,000
5.05%
-133,000
0.55%
06/30/2018
First Light Asset Management LLC
1,240,391
4.78%
613,806
2.42%
06/30/2018
BlackRock Fund Advisors
1,113,034
4.29%
93,912
0%
06/30/2018
Wasatch Advisors, Inc.
883,761
3.4%
138,571
0.09%
06/30/2018
Grandeur Peak Global Advisors LLC
705,226
2.72%
-77,977
0.32%
06/30/2018

About Oxford Immunotec Global

View Profile
Address
Milton Park
Abingdon Oxfordshire OX14 4RZ
United Kingdom
Employees -
Website http://oxfordimmunotec.com
Updated 07/08/2019
Oxford Immunotec Global Plc operates as a medical diagnostics company, which develops and commercializes proprietary tests for under-served immune-regulated conditions. Its current product lines and development activities principally focus on four areas: infectious diseases, transplantation, autoimmune and inflammatory disease and immune-oncology. Its products include T-SPOT.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.